Medicare Enrolled

Dr. David Chau, O.D.

Vision Therapy Optometrist · Sugar Land, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
19875 SOUTHWEST FWY STE 180, Sugar Land, TX 77479
7184580713
Registered in NPPES since 2012
NPI: 1306199328 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chau from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chau? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chau

Dr. David Chau is a vision therapy optometrist in Sugar Land, TX, with 13 years of NPI registration. Based on federal Medicare data, Dr. Chau performed 273 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Chau received a total of $4,175 from 23 pharmaceutical and/or device companies across 67 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chau is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years of NPI registration ▲ Top 48% volume in TX $4,175 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
273
Medicare services
Top 48% in TX for vision therapy optometrist
Not available
Unique patients (not deduplicated)
$231
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Microfluid analysis of tears
A laboratory test that analyzes tear fluid using microfluidic technology to measure specific biomarkers. This procedure helps evaluate the composition of tears for diagnostic purposes.
67 $22 $25
Amniotic membrane placement on eye surface
This procedure involves placing amniotic membrane on the surface of the eye to promote wound healing.
50 $1,014 $1,800
Eye photography
Photographic imaging of the interior structures of the eye.
30 $16 $50
Destruction of eyelid margin growth, 1.0 cm or less
This procedure involves the removal or destruction of a growth located on the margin of the eyelid that measures 1.0 centimeter or smaller.
29 $130 $500
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
25 $25 $85
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
24 $61 $90
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $90 $175
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
16 $96 $150
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
11 $107 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,175
Total received (2018-2024)
Avg $596/year across 7 years
Top 6% in TX for vision therapy optometrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
67
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,339
2023
$362
2022
$457
2021
$438
2020
$337
2019
$661
2018
$580

Payments by company (2024)

Bausch & Lomb Americas Inc.
$376
Carl Zeiss Meditec USA, Inc.
$162
CooperVision Inc.
$153
Dompe US, Inc.
$152
Optos, Inc.
$143
Alcon Vision LLC
$139
LKC Technologies, Inc.
$96
Glaukos Corporation
$89
Tarsus Pharmaceuticals, Inc.
$29
Top 3 companies account for 51.6% of 2024 payments
All-time payments by company (2018-2024) ›
Bausch & Lomb Americas Inc.
$587
Novartis Pharmaceuticals Corporation
$411
Bausch & Lomb, a division of Bausch Health US, LLC
$391
Optos, Inc.
$308
Carl Zeiss Meditec USA, Inc.
$307
Alcon Vision LLC
$300
Dompe US, Inc.
$260
OPTOS, INC.
$204
Shire North American Group Inc
$200
Alcon Laboratories Inc
$177
CooperVision Inc.
$153
Sun Pharmaceutical Industries Inc.
$126
Johnson & Johnson Surgical Vision, Inc.
$124
RxSight Inc
$106
LKC Technologies, Inc.
$96
TISSUETECH, INC.
$95
Aerie Pharmaceuticals, Inc.
$91
Glaukos Corporation
$89
Notal Vision, Inc.
$43
Allergan, Inc.
$36
Tarsus Pharmaceuticals, Inc.
$29
Sight Sciences, Inc.
$26
Eyevance Pharmaceuticals LLC
$15
Top 3 companies account for 33.3% of all-time payments
Associated products mentioned in payments ›
ALDEN SCLERAL ZENLENS · BIOTRUE · BIOTRUE ONE DAY · CE-marked KXLA system · CEQUA · CIRRUS HD-OCT · Cequa · Clear Care · DAILIES · Flarex · ILUX · INFUSE · INFUSE MULTIFOCAL · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LUMERA 700 · MIEBO · MiSight Contact Lens · Monaco · MyDay Contact Lens · NFC-700 · OXERVATE · P200DTx · PROKERA · RESTASIS MULTIDOSE · Rhopressa · Systane · TOTAL30 · TearCare · XDEMVY · XIIDRA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a vision therapy optometrist in Sugar Land?
Compare vision therapy optometrists in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse vision therapy optometrists nearby

Geographic Context

Vision therapy optometrists in nearby ZIP areas
6
County median income
$113,409
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chau is a mixed practice specialist, with moderate Medicare volume.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chau experienced with microfluid analysis of tears?
Based on Medicare claims data, Dr. Chau performed 67 microfluid analysis of tears services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Chau receive payments from pharmaceutical companies?
Yes. Dr. Chau received a total of $4,175 from 23 companies across 67 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chau's costs compare to other vision therapy optometrists in Sugar Land?
Dr. Chau's average Medicare payment per service is $231. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chau) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →